---
title: "PacBio SPRQ-Nx Chemistry Now Shipping Worldwide, Enabling Sub-$300 HiFi Genomes for Large Scale Projects and AI-Enhanced Sequencing | PACB Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287640220.md"
description: "PacBio SPRQ-Nx Chemistry Now Shipping Worldwide, Enabling Sub-$300 HiFi Genomes for Large Scale Projects and AI-Enhanced Sequencing | PACB Stock News"
datetime: "2026-05-26T05:05:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287640220.md)
  - [en](https://longbridge.com/en/news/287640220.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287640220.md)
---

# PacBio SPRQ-Nx Chemistry Now Shipping Worldwide, Enabling Sub-$300 HiFi Genomes for Large Scale Projects and AI-Enhanced Sequencing | PACB Stock News

PacBio SPRQ-Nx Chemistry Now Shipping Worldwide, Enabling Sub-$300 HiFi Genomes for Large Scale Projects and AI-Enhanced Sequencing | PACB Stock News

### Related Stocks

- [PACB.US](https://longbridge.com/en/quote/PACB.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)

## Related News & Research

- [PacBio and Lucid Genomics Announce Compatibility Collaboration to Advance Tertiary Analysis for Long-Read Sequencing | PACB Stock News](https://longbridge.com/en/news/283506957.md)
- [<![CDATA[Expanding Access to Whole-Genome Testing for Children: Q&A with Drs. Ryan Taft and Stacy Musone]]>](https://longbridge.com/en/news/281626394.md)
- [PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 1Q 2026: Revenue $37.18M, EPS ($0.03) — 10-Q Summary](https://longbridge.com/en/news/285778914.md)
- [PacBio expects $165M-$175M 2026 revenue as SPRQ-Nx ships later this month](https://longbridge.com/en/news/285683555.md)
- [Barclays Lowers Pacific Biosciences of California (NASDAQ:PACB) Price Target to $1.00](https://longbridge.com/en/news/282748678.md)